Available ablation energies to treat cT1 renal cell cancer: emerging technologies

PURPOSE: An increasing interest in percutaneous ablation of renal tumors has been caused by the increasing incidence of SRMs, the trend toward minimally invasive nephron-sparing treatments and the rapid development of local ablative technologies. In the era of shared decision making, patient prefere...

Descripción completa

Detalles Bibliográficos
Autores principales: Zondervan, P. J., Buijs, M., De Bruin, D. M., van Delden, O. M., Van Lienden, K. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Topic Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424924/
https://www.ncbi.nlm.nih.gov/pubmed/30448873
http://dx.doi.org/10.1007/s00345-018-2546-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424924/
https://www.ncbi.nlm.nih.gov/pubmed/30448873
http://dx.doi.org/10.1007/s00345-018-2546-6

Ejemplares similares